Stents Drug Eluting

Blog | Stents | February 13, 2017

Stents were the key focus of interventional cardiology for more than 20 years, but the focus has changed in recent...

Blog | January 30, 2017

DAIC has worked hard to bring useful technology news and resources to our readers. While we conduct reader surveys...

Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable | January 17, 2017 | Dave Fornell

One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable...

OCT, intravascular imaging, stent, good stent apposition on vessel wall, TRANSFORM-OCT study

An OCT image showing good stent strut apposition against the vessel wall.

News | Stents | January 13, 2017

January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (...

EXCEL Trial, TCT 2016, drug-eluting stents, CABG, surgery left main heart disease, LMCAD

Gregg W. Stone, M.D., presenting the EXCEL data at TCT 2016 during a standing room only late-breaking trial session.

Feature | Stents | January 12, 2017 | Dave Fornell

The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the...

Medinol, BIONICS study, 12-month results, TCT 2016, drug-eluting stent, EluNIR
News | Stents Drug Eluting | January 10, 2017

January 10, 2017 — Medinol announced in December positive twelve-month clinical results from the BIONICS study. The...

 PLATINUM DIVERSITY, stents in minorities and women
News | Cath Lab | November 09, 2016

November 9, 2016 — A dedicated stent study conducted exclusively in women and minority patients evaluated clinical...

Videos | Stents Bioresorbable | November 09, 2016

Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's...

Biotronik's Osiro stent, prison IV trial

Biotronik's Osiro ultra-thin strut, sirolimus-eluting stent.

News | Stents | November 09, 2016

November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin...

Videos | Cath Lab | November 08, 2016

David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute,...

OCT stent strut coverage

OCT imaging showing neointimal tissue coverage of metallic stent struts.

News | Stents | November 07, 2016

November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (...

biosensors Biofreedom stent
News | Stents | November 07, 2016

November 7, 2016 – The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high...

Bionics trial, Medinol, BioNIR stent, elastic polymer

Imaging of stent struts after expansion, showing the elastic polymer used on Medinol’s BioNIR stent does not crack or flake off, possibly leading to better patient outcomes. 

News | Stents | November 07, 2016

November 7, 2016 – The large multinational randomized BIONICS study found that a novel elastic polymer coated...

Medtronic, Resolute Integrity DES, drug-eluting stent, BIO-RESORT study, TCT 2016
News | Stents Drug Eluting | November 02, 2016

November 2, 2016 — Investigators recently unveiled clinical data from the independent BIO-RESORT study, representing...

Medtronic, Drug-Filled Stent, DFS, RevElution trial, first clinical data, TCT 2016, Stephen Worthley
News | Stents Drug Eluting | November 01, 2016

November 1, 2016 — Medtronic plc unveiled the first clinical outcomes of its novel...

Overlay Init